Mechanisms involved in sodium arsenite-induced apoptosis of human neutrophils.
Apoptosis is a distinct mechanism by which eukaryotic cells die. Factors governing the induction of polymorphonuclear leukocyte (PMN) apoptosis should be important in understanding resolution of acute inflammation. The mechanisms for induction of PMN apoptosis remain uncertain; however, oxidative stress has been suggested. The aims of this study were to determine whether reactive oxygen intermediates play a role in PMN apoptosis and to investigate inhibition of this process by selective use of antioxidants. PMN were isolated from 10 healthy volunteers. PMN (1 x 10(6) PMN/mL) were cultured in 40, 80, and 160 microM of arsenite for 2, 6, 12, 18, and 24 h. Apoptosis was assessed qualitatively by morphology and gel electrophoresis and quantitatively by CD16 receptor expression and propidium iodide DNA staining. There was a significant (P < 0.05) increase in the rate of apoptosis on incubation with arsenite (80 and 160 microM). To investigate the mechanism of this process, intracellular respiratory burst activity was measured following arsenite culture. We found that arsenite-induced PMN apoptosis correlated with an increase in intracellular respiratory burst. To further investigate the role of oxidative injury in inducing apoptosis, the antioxidants catalase, dimethyl sulfoxide (DMSO), glutathione (GSH), N-acetylcysteine (NAC), and taurine were investigated and we demonstrated that GSH, NAC, and taurine were significantly protective against arsenite-induced apoptosis. However, catalase and DMSO failed to induce protection. This study demonstrates that arsenite induces PMN apoptosis through an oxygen-dependent mechanism that can be prevented through selective antioxidants.
Watson
R W
RW
Department of Surgery, Royal College of Surgeons in Ireland, Beaumont Hospital, Dublin.
Redmond
H P
HP
Wang
J H
JH
Bouchier-Hayes
D
D
D000111:Acetylcysteine / Q000494:pharmacology; D000975:Antioxidants / Q000494:pharmacology*; D017209:Apoptosis / Q000187:drug effects*; D018053:Arsenites / Q000494:pharmacology*; D002374:Catalase / Q000494:pharmacology; D004121:Dimethyl Sulfoxide / Q000494:pharmacology; D005786:Gene Expression Regulation / Q000187:drug effects; D005978:Glutathione / Q000494:pharmacology; D006801:Humans; D016177:Macrophage-1 Antigen / Q000096:biosynthesis / Q000235:genetics; D009504:Neutrophils / Q000187:drug effects*; D017382:Reactive Oxygen Species; D017452:Receptors, IgG / Q000096:biosynthesis / Q000235:genetics; D016897:Respiratory Burst / Q000187:drug effects*; D017670:Sodium Compounds / Q000494:pharmacology*; D013654:Taurine / Q000494:pharmacology
D000975:Antioxidants; D018053:Arsenites; D016177:Macrophage-1 Antigen; D017382:Reactive Oxygen Species; D017452:Receptors, IgG; D017670:Sodium Compounds; D013654:Taurine; C017947:sodium arsenite; D002374:Catalase; D005978:Glutathione; D000111:Acetylcysteine; D004121:Dimethyl Sulfoxide